CCAP logo

Crescent Capital BDC, Inc. Stock Price

NasdaqGM:CCAP Community·US$407.9m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

CCAP Share Price Performance

US$11.16
-3.76 (-25.20%)
US$15.75
Fair Value
US$11.16
-3.76 (-25.20%)
29.1% undervalued intrinsic discount
US$15.75
Fair Value
Price US$11.16
AnalystConsensusTarget US$15.75
AnalystHighTarget US$19.00
AnalystLowTarget US$13.00

CCAP Community Narratives

·
Fair Value US$15.75 29.1% undervalued intrinsic discount

Private Credit Demand And Stable Funding Structure Will Support Long-Term Earnings Resilience

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$19 41.3% undervalued intrinsic discount

Private Credit Tailwinds And First Lien Focus Will Support A Stronger Future

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$13 14.2% undervalued intrinsic discount

Private Credit Adoption And Covenant Strength Will Shape Future Earnings Stability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$13
14.2% undervalued intrinsic discount
Revenue
-5.5% p.a.
Profit Margin
43.16%
Future PE
10.92x
Price in 2029
US$18.22
US$19
41.3% undervalued intrinsic discount
Revenue
-5.43% p.a.
Profit Margin
42.81%
Future PE
15.99x
Price in 2029
US$26.53
US$15.75
29.1% undervalued intrinsic discount
Revenue
-5.8% p.a.
Profit Margin
45.93%
Future PE
12.33x
Price in 2028
US$22.25

Trending Discussion

Updated Narratives

CCAP logo

Private Credit Adoption And Covenant Strength Will Shape Future Earnings Stability

Fair Value: US$13 14.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CCAP logo

Private Credit Tailwinds And First Lien Focus Will Support A Stronger Future

Fair Value: US$19 41.3% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CCAP logo

Private Credit Demand And Stable Funding Structure Will Support Long-Term Earnings Resilience

Fair Value: US$15.75 29.1% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Slight risk with moderate growth potential.

4 Risks
3 Rewards

Crescent Capital BDC, Inc. Key Details

US$163.1m

Revenue

US$0

Cost of Revenue

US$163.1m

Gross Profit

US$148.0m

Other Expenses

US$15.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.41
100.00%
9.25%
134.8%
View Full Analysis

About CCAP

Founded
2015
Employees
n/a
CEO
Jason Breaux
WebsiteView website
www.crescentbdc.com

Crescent Capital BDC, Inc. is as a business development company is a private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Recent CCAP News & Updates

Seeking Alpha May 19

Crescent Capital BDC: 13% Yield And A Discount Too Deep To Ignore

Summary Crescent Capital BDC trades near a 52-week low, offering a 13% yield and a deep 0.61x price-to-book discount. CCAP’s first-lien-heavy, diversified portfolio and recent management fee reductions support strong NII-to-dividend coverage at 113.5%. Nonaccruals rose to 3.6% of portfolio value, mainly in healthcare, but management actively manages these with meaningful control. Despite NAV pressure and higher leverage, the market may be overpricing credit risk, presenting value for patient income investors. Read the full article on Seeking Alpha

Recent updates

No updates